Loading…
3.0T 31P MR spectroscopy in assessment of response to antiviral therapy for chronic hepatitis C
AIM:To investigate the utility of phosphorus-31(31P)magnetic resonance spectroscopy(MRS)as a noninvasive test for assessment of response to interferon and ribavirin treatment in patients with different severities of hepatitis C virus infection.METHODS:Sixty chronic hepatitis C patients undergoing an...
Saved in:
Published in: | World journal of gastroenterology : WJG 2014-02, Vol.20 (8), p.2107-2112 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | AIM:To investigate the utility of phosphorus-31(31P)magnetic resonance spectroscopy(MRS)as a noninvasive test for assessment of response to interferon and ribavirin treatment in patients with different severities of hepatitis C virus infection.METHODS:Sixty chronic hepatitis C patients undergoing antiviral therapy with interferon and ribavirin underwent 31P MRS at 3.0T before treatment,6 mo after the start of treatment,and 1 year after the start of treatment.RESULTS:The phosphomonoester(PME)/phosphodiester(PDE)ratio at 6 mo after the start of antiviral therapy in the Child-Pugh B and C groups were significantly higher than those before therapy,but this was not seen in the Child-Pugh A group.In the antiviral therapy group,the PME/PDE ratios had decreased on follow-up MR spectroscopy.However,in the virological nonresponder group,the PME/PDE ratios on follow-up imaging were similar to the baseline values.CONCLUSION:31P MRS can be used to provide biochemical information on hepatic metabolic processes.This study indicates that the PME/PDE ratio can be used as an indicator of response to antiviral treatment in chronic hepatitis C patients. |
---|---|
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v20.i8.2107 |